Anchiano Therapeutics Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was USD 2.449 million compared to USD 7.168 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.19 a year ago. For the nine months, net loss was USD 9.465 million compared to USD 21.520 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.64 a year ago.